A collection of sources which have published success rates can be found at the Long Covid Apheresis Community (LCA Community): https://lcacommunity.org/research
The results published by the LCA Community have been confirmed at the ISFA2023:
ISFA 2023 (International Society for Apheresis World Conference)
Science 2024 - new study looking at the relation between microclots and immune damage in Long Covid:
Quote: '...coagulation in Long Covid is indicated by the detection of circulating fibrinolysis-resistant microclots that are enriched in vWF, C7, acute-phase serum amyloid proteins, and fibrin, proteins identified in the proteomics screen by Cervia-Hasler et al. as contributors to Long Covid.'
Full study: https://www.science.org/doi/10.1126/science.adn1077
In simpler terms, this study investigates the reasons behind persistent symptoms in some people after recovering from COVID-19, a condition known as Long Covid. The researchers found that Long Covid patients have ongoing activation of the immune system, specifically the complement system, which leads to inflammation and blood clot formation. Unlike during acute COVID-19, where the liver plays a major role in immune responses, in Long Covid, the inflammation seems to be more localized, involving tissues and immune cells. The study suggests that this persistent immune activation, particularly in the complement system, contributes to the symptoms experienced by Long Covid patients.
The researchers identified specific proteins, such as pentraxin 3 and complement components, that are associated with Long Covid. The complement system, when uncontrolled, can cause damage to cells and blood vessels. In Long Covid patients, there is evidence of excessive complement activation, leading to inflammation and microclot formation. This ongoing inflammatory state, even in the absence of widespread blood clotting, can explain the lingering symptoms observed in Long Covid, such as fatigue and cognitive issues.
Additionally, the study found imbalances in factors related to blood clotting, suggesting a potential mechanism for thromboinflammation in Long Covid. While the exact reasons for the persistent immune activation and clotting in Long Covid are not fully understood, the study indicates that targeting specific components of the immune and clotting systems could be a potential avenue for treatment in Long Covid.
H.E.L.P. Apheresis addresses most if not all of the above. Microclots, Hypercoagulation, Inflammation, Pathogens to list just a few modes of action of H.E.L.P. Apheresis. The rest can be addressed by other elements of the Combination Therapy of 'The Cyprus Protocol'.
You will find extensive information on our blog post about different types of Apheresis and which type is suitable for which purpose HERE